Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             23 results found
no title author magazine year volume issue page(s) type
1 Activity of the combination of high-dose epirubicin with gemcitabine in advanced non-small-cell lung cancer Van Putten, John W.G
 2001
 34 S4 p. 61-64
4 p.
 article
2 ALIMTA® (pemetrexed disodium, LY231514, MTA): clinical experience in non-small cell lung cancer Novello, S
 2001
 34 S4 p. 107-109
3 p.
 article
3 Angiogenesis and antiangiogenic agents in non-small cell lung cancer Galligioni, Enzo
 2001
 34 S4 p. 3-7
5 p.
 article
4 Anthacyclines in non-small cell lung cancer Pronzato, Paolo
 2001
 34 S4 p. 57-59
3 p.
 article
5 A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis Santo, Antonio
 2001
 34 S4 p. 15-20
6 p.
 article
6 Author index 2001
 34 S4 p. 117-118
2 p.
 article
7 Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancer Kakolyris, S
 2001
 34 S4 p. 71-76
6 p.
 article
8 Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial Georgoulias, V.
 2001
 34 S4 p. 47-51
5 p.
 article
9 Contents 2001
 34 S4 p. v-vi
nvt p.
 article
10 Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer: early results of an international phase III study Mattson, K
 2001
 34 S4 p. 21-23
3 p.
 article
11 Gemcitabine and pemetrexed disodium combinations in vitro and in vivo Adjei, Alex A
 2001
 34 S4 p. 103-105
3 p.
 article
12 Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial Frasci, Giuseppe
 2001
 34 S4 p. 65-69
5 p.
 article
13 Induction chemotherapy with gemcitabine and cisplatin in stage III non-small cell lung cancer Rinaldi, Massimo
 2001
 34 S4 p. 25-30
6 p.
 article
14 Is there a standard strategy in the management of locally advanced non-small cell lung cancer? Novello, S
 2001
 34 S4 p. 9-14
6 p.
 article
15 Paclitaxel-based combination chemotherapy in advanced non-small cell lung cancer Greco, F.Anthony
 2001
 34 S4 p. 53-56
4 p.
 article
16 Potential of 5-aza-2′-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer Momparler, Richard L
 2001
 34 S4 p. 111-115
5 p.
 article
17 Preface Cartei, Giuseppe
 2001
 34 S4 p. 1-
1 p.
 article
18 Radiosensitization with chemotherapeutic agents Caffo, Orazio
 2001
 34 S4 p. 81-90
10 p.
 article
19 Response to chemotherapy, quality of life benefits and survival in advanced non-small cell lung cancer: review of literature results Klastersky, J.
 2001
 34 S4 p. 95-101
7 p.
 article
20 Role of erythropoietin in the treatment of lung cancer associated anaemia Scagliotti, G.V
 2001
 34 S4 p. 91-94
4 p.
 article
21 Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study Agelaki, Sophia
 2001
 34 S4 p. 77-80
4 p.
 article
22 Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer Tumolo, S
 2001
 34 S4 p. 37-46
10 p.
 article
23 Weekly docetaxel as II line therapy in non-small cell lung cancer: an interim analysis of a phase II study Valerio, Maria Rosaria
 2001
 34 S4 p. 31-35
5 p.
 article
                             23 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands